drugset / Trial / NCT01104844

Maxi-Analgesic Phase 2 Study to Compare the Analgesic Effects in Different Dosing Groups to Treat Teeth Extraction Pain

NCT01104844

Phase 2 Withdrawn AFT Pharmaceuticals, Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to examine the dose response relationship in the treatment of dental pain (teeth extraction) for the different potential doses of the investigational drug, i.e. 2 tablets, 1 tablet or ½ a tablet given 4 times a day.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 125 mg Oral
Comparator Acetaminophen Small molecule 250 mg Oral
Comparator Acetaminophen Small molecule 500 mg Oral
Comparator Ibuprofen Small molecule 37.5 mg Oral
Comparator Ibuprofen Small molecule 75 mg Oral
Comparator Ibuprofen Small molecule 150 mg Oral
Comparator Ibuprofen Small molecule 300 mg Oral

Indications